Tuesday, August 4 4:30–6pm
Conversations that Count: Building Skills to Motivate Sustainable Weight Change
Wednesday, August 5 1:10–2:25pm
EKGs Made Practical: Rhythms, Rates, and Red Flags for Primary Care
Wednesday, August 5 7:30–8:30am
Live Ortho Demonstration: Shoulder and Knee Exams for Primary Care
Tuesday, August 4 1:30–2:30pm
Cardiology Guidelines to Practice: 2026 Updates in HTN and Lipid Management
Tuesday, August 4 3:30–4:15pm
Rash Decisions: Recognizing and Managing Common Skin Conditions
Wednesday, August 5 12–1pm
What Should I Do Next? How to Approach Unexpected Labs in Primary Care
Wednesday, August 5 2:25–3:10pm
Wednesday, August 5 10–11:30am
Managing Pain in the Real World: Challenging Cases in Pain Management and OUD
Tuesday, August 4 7:30–8:30am
AI - The Good, The Bad, and The Ugly (Navigating the New Reality of AI in Medicine)
Wednesday, August 5 10–11:30am
Managing Pain in the Real World: Challenging Cases in Pain Management and OUD
Wednesday, August 5 1:10–2:25pm
EKGs Made Practical: Rhythms, Rates, and Red Flags for Primary Care
Tuesday, August 4 8:30–9:30am
Reframing ADHD: New Science, New Treatments, New Perspectives
Tuesday, August 4 8:30–9:30am
Reframing ADHD: New Science, New Treatments, New Perspectives
Tuesday, August 4 11:30am–12:30pm
Tuesday, August 4 4:30–6pm
Conversations that Count: Building Skills to Motivate Sustainable Weight Change
Earn CME/CE credits in Tampa.
Register NowDisclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Andrew E. Budson, MD
- Advisor: AbbVie, Eli Lilly; Consultant: Eli Lilly; Speaker: Eli Lilly; Researcher: Vox Neuro, Eisai
- Amy Clouse, MD, FAAFP
- Stock Holder (publicly traded company): Eli Lilly and Novo Nordisk Inc.
- Lisa M. Ferreira, MD, FOMA, DABOM, DABL
- Speaker: Eli Lilly and Novo Nordisk Inc.
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Consultant: OptumRx
- Stephen N. Henry, DO, MS
- No relevant financial relationships disclosed.
- Heather M. Johnson, MD, MS, MMM, FACC, FAHA, FASPC
- Speaker: Esperion; Consultant: Esperion, Amgen, Novartis, Medtronic
- Jonette Keri, MD, PhD
- Advisor: Almirall; Advisor: Sanofi
- Pamela Kushner, MD, FAAFP
- Advisor: GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Bausch/SALIX, Haleon, Verdiva, Abbott, Corcept, and Bayer; Speaker: GlaxoSmithKline, Boehringer Ingelheim, Phathom, AstraZeneca, Novo Nordisk, Lilly, Janssen, Haleon, Corcept, and Lilly
- Petros Levounis, MD, MA
- No relevant financial relationships disclosed
- Peter Lin, MD, CCFP
- Speaker: Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eisai, Eli Lilly, GlaxoSmithKline, Medtronic, Merck, Moderna, Novo Nordisk, Pfizer, Sanofi
- Vani Potluri, MD, DABOM
- No relevant financial relationships disclosed.
- Ajay Shah, MD
- No relevant financial relationships disclosed.
- Elliot B. Tapper, MD
- Information to come
- Charles Vega, MD, FAAFP
- Consultant: GlaxoSmithKline, Boehringer Ingelheim, Exact Sciences
- Shirah Vollmer, MD
- No relevant financial relationships disclosed.
Other Disclosures
Pamela Kushner, MD, FAAFP (Reviewer): Speaker and Advisor for GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novo Nordisk, Lilly, Haleon, Corcept; Speaker for Phathom, Janssen; Advisor for Bausch/Salix, Bayer, Verdiva, Abbott
Charles Vega, MD, FAAFP (Moderator): Consultant for GlaxoSmithKline, Boehringer Ingelheim, Exact Sciences
All relevant relationships have been mitigated by Pri-Med Institute. All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.